Substance Abuse Research and Treatment,
Journal Year:
2022,
Volume and Issue:
16
Published: Jan. 1, 2022
Opioid
use
disorder
(OUD)
through
prescription
opioid
misuse,
heroin,
and
illicitly
manufactured
fentanyl
has
increased
dramatically
in
the
past
20
years.
Medications
to
treat
(MOUD)
is
considered
gold
standard
for
treating
disorders
but
uptake
remains
low.
Recently,
Madden
argued
that
addition
stigma
assigned
substance
people
with
SUD,
MOUDs
also
are
stigmatized,
a
process
she
labels
intervention
distinguish
it
from
condition
(ie,
of
SUD)
.
In
this
paper,
we
examine
MOUD
related
perspective
who
opioids
(PWUO)
key
informants
play
some
role
providing
or
referring
drug
treatment.
Providers
PWOU
often
viewed
as
one
replacing
another
which
discouraged
providers
recommending
PWUO
accepting
MOUD.
was
expressed
by
providers’
exaggerated
fear
diversion.
The
extent
accepted
legitimate
treatment
varied
influenced
perceptions
goals
length
time
should
be
used
many
feeling
only
temporary
tool
while
work
on
other
goals.
This
led
tapering
off
after
Some
mistrust
stemming
their
previous
experiences
over-prescription
pain
current
crisis.
Results
study
suggest
proportion
unlikely
increase
without
addressing
among
seeking
Addiction,
Journal Year:
2020,
Volume and Issue:
116(6), P. 1505 - 1511
Published: Nov. 3, 2020
Abstract
Background
and
Aims
Patients
with
opioid
use
disorder
(OUD)
must
be
able
to
obtain
prescribed
buprenorphine/naloxone
films
(BUP/NX)
naloxone
nasal
spray
(NNS)
from
a
pharmacy
promptly
reduce
risk
for
recurrence
of
subsequent
morbidity
mortality.
Telephone
audits
have
identified
concerning
gaps
in
availability
NNS
within
US
pharmacies,
but
the
BUP/NX
has
not
been
rigorously
evaluated.
This
study
estimated
state
Texas
compared
by
type
metropolitan
status.
Design
A
cross‐sectional
telephone
audit
secret
shopper
approach
conducted
18
May
2020
7
June
2020.
Setting
Participants
random
sample
800
5078
(16%)
community
pharmacies
licensed
State
Board
Pharmacy.
Measurements
Primary
outcomes
included
1‐week
supply
generic
8/2
mg
single
unit
4
mg,
overall
type.
Secondary
willingness
time‐frame
order
if
unavailable.
Findings
Data
704
(471
chain,
233
independent)
were
analyses.
Of
these,
34.1%
(45.0%
chains
versus
12.0%
independents,
P
<
0.0001)
willing
dispense
NNS.
alone
was
available
42.2%
(52.4%
21.5%
0.0001).
60.1%
(77.9%
24.0%
397
unavailable,
62.2%
(73.9%
48.0%
indicated
order.
Conclusions
Most
do
appear
patients
timely
manner.
Deficiencies
are
markedly
more
pronounced
independent
chain
pharmacies.
New England Journal of Medicine,
Journal Year:
2020,
Volume and Issue:
383(8), P. 703 - 705
Published: Aug. 19, 2020
Interview
with
Dr.
Justin
Berk
on
starting
patients
recently
released
from
incarceration
treatment
for
opioid
use
disorder.
(10:59)Download
Federal
and
state
initiatives
designed
to
increase
access
buprenorphine
have
focused
nearly
exclusively
physicians
other
prescribers.
Yet
their
success
depends
entirely
whether
pharmacists
dispense
who
present
a
prescription.
The Journal of Rural Health,
Journal Year:
2021,
Volume and Issue:
37(3), P. 467 - 472
Published: March 15, 2021
Abstract
Purpose
Tracking
changes
in
care
utilization
of
medication
for
opioid
use
disorder
(MOUD)
services
before,
during,
and
after
COVID‐19‐associated
policy
service
delivery
a
mixed
rural
micropolitan
setting.
Methods
Using
retrospective,
open‐cohort
design,
we
examined
visit
data
MOUD
patients
at
family
medicine
clinic
across
three
identified
periods:
pre‐COVID,
COVID
transition,
COVID.
Outcome
measures
include
the
number
type
visits
(in‐person
or
telehealth),
new
entering
treatment,
urine
drug
screens
performed.
Distance
from
patient
residence
to
was
calculated
assess
access
areas.
Goodness‐of‐Fit
Chi‐Square
tests
ANOVAs
were
used
identify
differences
between
time
periods.
Findings
Total
increased
during
(436
pre
vs.
581
post,
p
<
0.001),
while
overall
remained
constant
(33
29
=
0.755).
The
clinic's
catchment
area
size,
with
coming
primarily
Length
(21.1
days
43.5
0.001).
Conclusions
patterns
this
period
demonstrate
effectiveness
telehealth
area.
Policy
allowing
be
delivered
via
telehealth,
waiving
need
in‐person
initiation
MOUD,
Medicaid
compensation
may
play
valuable
role
improving
COVID‐19
pandemic
beyond.
